Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report-Reference-Cited by-同舟云学术

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report

Published:2014-01-14 Issue:1 Volume:13 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Nakamura Ikuko,Oyama Jun-ichi,Komoda Hiroshi,Shiraki Aya,Sakamoto Yoshiko,Taguchi Isao,Hiwatashi Atsushi,Komatsu Aiko,Takeuchi Masayoshi,Yamagishi Sho-ichi,Inoue Teruo,Node Koichi

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1186/1475-2840-13-15.pdf

Reference45 articles.

1. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87: 4-14. 10.1016/j.diabres.2009.10.007.

2. Fujimoto WY, Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW: Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance. Diabetologia. 1994, 37: 524-532. 10.1007/s001250050142.

3. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14: 173-194. 10.2337/diacare.14.3.173.

4. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002, 105: 2696-2698. 10.1161/01.CIR.0000020650.86137.84.

5. Reaven GM: Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607. 10.2337/diab.37.12.1595.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nature-based solution for regulating the inflammatory phase of diabetic wound healing using a cold atmospheric plasma;Cell Reports Physical Science;2024-08

2. Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial;Perspectives in Clinical Research;2024-07-10

3. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes;World Journal of Diabetes;2023-08-15

4. Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study;Frontiers in Endocrinology;2023-08-11

5. Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus;Scientific Reports;2023-04-18